AVE 33.3% 0.2¢ avecho biotechnology limited

transdermal patch, page-7

  1. 10,009 Posts.
    WL, I have been posting here for a while that the big money here is repatenting other companies blockbuster drugs. Generic or patented drugs can be reengineered with TMP made much safer and more effective and with lower doses and therefore less side effects. POH can do this themselves or partner with any other company. Hundres of drugs with billions of dollars wirth of sale.

    This is one very rare company, it is a delivery platform for others drugs. Every one of these trials that further prove up TMP technology increase the value of the company. The market hasn't understood this yet but they will at some stage.

    POH can use sprays,gels,patches,pills and other methods of delivery. Once the TMP is accepted by the FDA then hundres of drugs could be quickly approved in combo with TMP. This won,t take years to get to market as with new compounds.

    I think this was a very good announcement and signals that the company is moving very fast towards commercialisation of its technology. The Nestle deal seems like a secondary sideshow compared to TMP . I celebrated by buying more stock today.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.